Badrinath Sangle, M. Pharma, GB. Lean Six Sigma

Badrinath Sangle serves as the CEO and Director of Vivotech Research Lab Pvt. Ltd., where he leverages his extensive expertise in business development and project management within the Clinical Research Organization (CRO) landscape. Under his leadership, Vivotech has positioned itself as a full-service provider of clinical research solutions, specializing in Phase I-IV clinical trials, bioequivalence studies, and clinical endpoint studies tailored for the pharmaceutical, biotechnology, and medical device sectors.

Badrinath's role encompasses the entire business development and project management lifecycle, from opportunity identification to project execution and closure. His adeptness in budget negotiation and deal closure ensures that Vivotech not only secures valuable contracts but also delivers on its commitments with precision and efficiency. His deep understanding of Good Clinical Practice (GCP) and International Conference on Harmonisation (ICH-GCP) guidelines enables him to maintain the highest standards in regulatory compliance and clinical operations, fostering trust and reliability with clients.

Key projects under Badrinath's direction have included large-scale clinical trials that required meticulous planning and execution, showcasing his ability to manage complex regulatory submissions and validation processes. His commitment to adhering to Good Laboratory Practice (GLP) and developing robust Standard Operating Procedures (SOPs) has been instrumental in enhancing operational efficiencies within the organization. Badrinath's strategic vision and hands-on approach not only drive Vivotech's growth but also contribute significantly to advancing the clinical research field, ensuring that innovative therapies reach the market effectively and safely.